» Articles » PMID: 27060712

Role of Serial EUS-guided FNA on Pancreatic Cystic Neoplasms: A retrospective Analysis of Repeat Carcinoembryonic Antigen Measurements

Overview
Date 2016 Apr 10
PMID 27060712
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Pancreatic cystic neoplasms (PCNs) often need interval surveillance, including repeat EUS, but the role of repeat FNA with fluid analysis is poorly defined. The aim of this analysis is to evaluate the potential clinical significance of serial carcinoembryonic antigen (CEA) measurements by EUS-guided FNA (EUS-FNA) in the surveillance for PCNs.

Patients: Patients who underwent EUS-FNA for PCNs were studied retrospectively. EUS-FNA findings were compared between index and prior procedures among patients who underwent repeat EUS-FNA.

Results: A total of 400 patients with PCNs underwent EUS-FNA. Eighty-seven of those patients had prior EUS-FNA with cyst fluid analysis. Patients with repeat FNA were significantly more likely to have multiple cysts (57% vs 41%; P = .008), multilocular cysts (75% vs 62%; P = .042), connection to pancreatic duct (33% vs 18%; P = .005), and higher initial CEA levels (94.8 vs 25.6 ng/mL; P = .003) compared with patients who had only a single FNA. A comparison of prior and index FNAs did not show significant differences in EUS or cyst fluid analysis findings. After log transformation, the association between CEA level at prior and index FNA was moderate (R = 0.626; P < .001), but cystic fluid CEA classification with a cutoff value of 192 ng/mL changed in 17 patients (20%), without significant changes in EUS findings.

Conclusions: Repeat surveillance EUS-FNA resulted in stable CEA levels in the majority of patients, with spurious fluctuations of CEA in approximately 20% of patients. These data call into question any clinical significance attributed to an isolated interval rise in CEA level, especially in light of a stable EUS examination.

Citing Articles

Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases.

Oyama H, Hamada T, Nakai Y, Tanaka M, Endo G, Hakuta R J Gastroenterol. 2023; 58(10):1068-1080.

PMID: 37507590 PMC: 10522754. DOI: 10.1007/s00535-023-02028-0.


Serial EUS-Guided FNA for the Surveillance of Pancreatic Cysts: A Study of Long-Term Performance of Tumor Markers.

Rahal M, DeWitt J, Patel H, Schmidt C, Ceppa E, Simpson R Dig Dis Sci. 2022; 67(11):5248-5255.

PMID: 35229208 PMC: 10153767. DOI: 10.1007/s10620-022-07427-6.


Confocal endomicroscopy for evaluation of pancreatic cystic lesions: a systematic review and international Delphi consensus report.

Napoleon B, Krishna S, Marco B, Carr-Locke D, Chang K, Gines A Endosc Int Open. 2020; 8(11):E1566-E1581.

PMID: 33140012 PMC: 7581463. DOI: 10.1055/a-1229-4156.


Glycopatterns and Glycoproteins Changes in MCN and SCN: A Prospective Cohort Study.

Wang Y, Sun Y, Feng J, Li Z, Yu H, Ding X Biomed Res Int. 2019; 2019:2871289.

PMID: 31467879 PMC: 6699316. DOI: 10.1155/2019/2871289.


A health economic evaluation of needle-based confocal laser endomicroscopy for the diagnosis of pancreatic cysts.

Le Pen C, Palazzo L, Napoleon B Endosc Int Open. 2017; 5(10):E987-E995.

PMID: 29159273 PMC: 5633408. DOI: 10.1055/s-0043-117947.


References
1.
Springer S, Wang Y, Dal Molin M, Masica D, Jiao Y, Kinde I . A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology. 2015; 149(6):1501-10. PMC: 4782782. DOI: 10.1053/j.gastro.2015.07.041. View

2.
Ahmad N, Kochman M, Brensinger C, Brugge W, Faigel D, Gress F . Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc. 2003; 58(1):59-64. DOI: 10.1067/mge.2003.298. View

3.
Park W, Mascarenhas R, Palaez-Luna M, Smyrk T, OKane D, Clain J . Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas. 2010; 40(1):42-5. PMC: 3005131. DOI: 10.1097/MPA.0b013e3181f69f36. View

4.
Das A, Ngamruengphong S, Nagendra S, Chak A . Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointest Endosc. 2009; 70(4):690-699.e6. DOI: 10.1016/j.gie.2009.02.013. View

5.
Brugge W, Lewandrowski K, Lee-Lewandrowski E, Centeno B, Szydlo T, Regan S . Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; 126(5):1330-6. DOI: 10.1053/j.gastro.2004.02.013. View